Recommended dosage of linezolid in the treatment of pulmonary tuberculosis

For the application of linezolid in the treatment of pulmonary tuberculosis, the accuracy of its dosage is undoubtedly a core issue. It is not only related to the effectiveness of treatment, but also directly affects the life safety of patients. Therefore, the severity of the patient's condition and individual tolerability must be considered when determining the dose of linezolid to ensure that the treatment is both effective and safe.

For adult patients with pulmonary tuberculosis, the recommended dosage of linezolid is not static, but needs to be flexibly adjusted according to the patient's specific condition. Typically, the recommended initial dose of linezolid for adults and adolescents 12 years and older is 600 mg twice daily for patients with hospital-acquired pneumonia, community-acquired pneumonia, concurrent skin and skin and soft tissue infections, and vancomycin-resistant Enterococcus faecalis infections (including concurrent bacteremia). For pediatric patients under 12 years old, it is recommended to adjust the dose according to body weight and take 10 mg/kg/kg every 8 hours.

For uncomplicated skin and skin and soft tissue infections, the dosage of linezolid varies. It is recommended to take 400orally every 12 hours for adults and adolescent patients 12 years old and above pan>mg (in some cases adolescents may need to take 600mg orally every 12 hours), and pan>Patients under 5 years old are recommended to take 10ml every 8 hours Grams/kg, continuous administration for 10 to 14 days. For patients aged 5 to 11 years old, oral administration is recommended every 12 hours 10mg/kg, the same continuous medication for 10 to 14 days.

During the actual treatment process, doctors will make timely adjustments to the dose of linezolid based on the patient's specific condition changes and treatment response. Especially when treating severe and refractory tuberculous meningitis, the recommended dose for adults and children over 12 years of age may be appropriately increased to better control the disease. In addition, for other types of infections such as complicated skin and skin and soft tissue infections, community-acquired pneumonia and associated bacteremia, the dosage and method of linezolid will be adjusted accordingly according to the specific situation to ensure the pertinence and effectiveness of the treatment plan.

References:

https://publications.ersnet.org/content/erj/34/6/1492